多西环素暴露后预防和非目标抗菌素耐药性:在性网络中的潜在放大
Manon Roberts1, Peter Davis1,2
1University of Oxford, Oxford, UK.
The Journal of infectious diseases
|August 19, 2025
概括
对多西环素暴露后预防 (doxyPEP) 可能会引起对抗菌素耐药性 (AMR) 的担忧. 需要进一步的研究来了解其对开始性细菌和性网络中耐药性传播的影响.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 公共卫生 公共卫生
背景情况:
- 在预防性传播感染的临床指南中,越来越多地建议使用多西环素暴露后预防 (doxyPEP).
- 人们对使用多西环林来驱动抗菌素耐药性 (AMR) 的潜力存在担忧.
- 对口腔大开始性细菌的非目标效应和性网络内的耐药性传播是研究的关键领域.
研究的目的:
- 评估多克西PEP对抗菌素耐药性的影响.
- 为了研究doxyPEP对口腔喉的开始性细菌的影响.
- 了解通过亲密行为促进抗性传播的潜力.
主要方法:
- 本研究重点分析与doxyPEP相关的现有数据和指导方针.
- 它涉及对有关AMR和开始性细菌的文献的审查.
- 这项研究考虑了性网络在抵抗传播中的作用.
主要成果:
- 需要注意的是,DoxyPEP被列入了指导方针.
- 抗菌素耐药性 (AMR) 仍然是一个重大问题.
- 存在对共生细菌和耐药性传播的非目标影响的可能性.
结论:
- 虽然doxyPEP是一种有价值的工具,但对AMR的持续监测至关重要.
- 了解对共生细菌的生态影响至关重要.
- 进一步的研究应该解决性网络中耐药性传播的动态.
关键词:
抗微生物耐药性 抗微生物耐药性细菌 细菌 细菌是一种细菌.在多西环林暴露后进行预防.耳鼻喉 (oropharynx) 是一个性传播感染性传播感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性更多相关视频
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
8.0K
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
2.0K
相关概念视频
Sexually Transmitted Infections
411
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
411
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Antibiotic Selection
55.2K
Overview
55.2K
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
